Fortrea Holdings Inc. FTRE 深 沪
等待开盘 07-07 09:30:00 美东时间
17.66
+0.380
+2.20%
华盛通- 最 高17.98
- 今 开17.29
- 成交量 55.91万股
- 最 低 16.90
- 昨 收 17.28
- 总市值 167.06万
- 52周最高 18.67
- 市盈率 静 --
- 换手率 591.01%
- 52周最低 4.455
- 委 比 -32.09%
- 总股本 9.46万
- 历史最高 41.02
- 量 比 0.32
- 振 幅 6.25%
- 历史最低 3.97
- 每 手 1
- 风险率 3.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多分析师解读医疗健康企业：Viridian Therapeutics（VRDN）与Fortrea Holdings Inc.（FTRE）
医疗保健领域两名分析师分别对VRDN（维里迪安治疗公司）、FTRE（富驰控股有限公司）给出看涨评级。 VRDN相关关键数据：上周五收盘价17.90美元，华尔街共...
06-30 10:32
Fortrea Appoints New CFO and Reaffirms 2026 Outlook
The latest update is out from Fortrea Holdings Inc. ( ($FTRE) ). On June 26, 20...
06-27 04:57
Fortrea names Jason Knoblauch as CFO
Fortrea (FTRE) has appointed Jason Knoblauch as chief financial officer, effective July 6, 2026. Knoblauch joins Fortrea from Clario, where he served as CFO. He will succeed Jill McConnell, who is ste...
06-26 19:22
Fortrea Appoints Jason Knoblauch As CFO, Effective July 6, Succeeding Jill Mcconnell
Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that Jason Knoblauch has been appointed as chief financial officer, effective July 6, 2026. He will succeed Jill McConnell, who is stepping down after successfully helping the Company become...
06-26 19:07
Fortrea reiterates 2026 revenue outlook of $2.55 billion-$2.65 billion
Fortrea reiterates 2026 revenue outlook of $2.55 billion-$2.65 billion Fortrea reiterated full-year 2026 guidance, projecting revenue of $2.55 billion-$2.65 billion. Adjusted EBITDA outlook held at $190 million-$220 million. Guidance reaffirmation accompanied a CFO transition, with Jason Knoblauch s
06-26 19:00
美股大行评级 | 瑞银上调超微公司目标价从455美元升至670美元，上调ARM目标价从260美元升至470美元；美银证券上调台积电目标价从490美元升至590美元
今日重点评级关注：Jones Trading：维持Definium Therapeutics"买入"评级，目标价从61美元升至74美元；韦德布什：维持Cerebras Systems"跑赢大市"评级，目标价从270美元升至280美元
06-25 11:32
Okta To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BTIG raised the price target for International Seaways Inc (NYSE:INSW) from $90 to $100. BTIG analyst Gregory ...
06-24 20:56
Barclays Maintains Equal-Weight on Fortrea Holdings, Raises Price Target to $18
Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Equal-Weight and raises the price target from $16 to $18.
06-24 17:24
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
